Artificial Intelligence (AI) is revolutionizing the pharmaceutical sector by promising a significant acceleration in drug discovery. The traditional drug development timeline, which often spans over ten years, may be dramatically shortened as AI excels in processing large datasets and decoding
With a $1.2 billion dollar acquisition of Gracell Biotechnologies, pharmaceutical giant AstraZeneca has firmly entrenched itself in the Asian market. The company is not only expanding its footprint, but also broadening its scope with its foray into cell therapy—Gracell’s specialized offering. With h
For patients living with Relapsed or Refractory Multiple Myeloma (RRMM), life revolves around treatment cycles, clinical trials, brief periods of good health, and the uncertainty of when they will be sick again. By definition, RRMM is a rare type of incurable blood cancer referred to as relapsed
There is no question that cardiovascular diseases (CVDs) are a top priority for scientists and healthcare experts. According to the World Health Organization (WHO), CVDs are the leading cause of death globally , with 17.9 million people dying every year. The most common CVDs include coronary heart
People around the world, scientists, and policymakers have undoubtedly learned numerous lessons from the COVID-19 pandemic. This healthcare crisis has shown the importance of being prepared to face a new epidemic or pandemic, as well as the need to develop effective tests, vaccines and treatments
The recent healthcare crisis differed from earlier emergencies because it has spread to impact most industries and multiple financial systems around the world. As the COVID-19 pandemic continued for more than two years, countries around the world struggled to keep their healthcare systems working,
